Exacerbation of COVID 19 in Hypertensive Patients ( A review)

Naser, Noor H.; Alibeg, Ammar Abdul Aziz

doi:10.31351/vol30iss2pp23-30

Cited by 7 publications

(6 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The accidental withdrawal from ACE or ARB medication in patients who have hypertension or heart failure could result in clinical instability and negative health outcomes. This finding emphasizes the importance of continuing such medicine even for patients who are infected with COVID-19 (14) .…”

Section: Introductionmentioning

confidence: 80%

Effects of Fixed Orthodontic Appliance with Antihypertensive Drugs on the Body Weight of Experimental Rats

Mahdi,

Saloom,

Kashmola

2023

J Bagh Coll Dent

View full text Add to dashboard Cite

Background: This study aims to investigate the effect of fixed orthodontic appliances and/or antihypertensive drugs on the weight of experimental rats. Materials and Methods: Thir-ty-six male Wistar albino rats were subjected to a split-mouth design study, in which an orthodontic appliance was inserted in one side to move the first molar mesially for 2 weeks while the other side acted as a control to tooth movement. The rats were allocated into three groups: group A (n = 12), without any pharmacological treatment; group B (n = 12), subcu-taneous injection of bisoprolol fumarate (5 mg/kg) daily; and group C (n = 12), subcutaneous injection of valsartan (10 mg/kg) daily. A fixed orthodontic appliance with a closing coil spring delivering 50 gm of force was used to move the first molar mesially while the incisors served as an anchor unit. The weight of the rats was measured on days 1 (the day of appli-ance insertion), 7, and 14. Results: No significant (P > 0.05) difference in the body weight of rats was found among the three groups at each time point; however, significant (P < 0.05) weight loss was noted after the first and second week of the experiment in all study groups. Conclusion: The body weight loss of rats following the insertion of a fixed orthodontic ap-pliance could be related to the effects of the appliance rather than the administered antihy-pertensive drugs.

show abstract

Section: Introductionmentioning

confidence: 80%

Effects of Fixed Orthodontic Appliance with Antihypertensive Drugs on the Body Weight of Experimental Rats

Mahdi,

Saloom,

Kashmola

2023

J Bagh Coll Dent

View full text Add to dashboard Cite

show abstract

“…During an emergency meeting held by the World Health Organization on January 30, 2020, COVID-19 was named an international public health emergency of international concern [5]. Since it was found in December 2019, the virus has quickly spread worldwide, causing chaos in all parts of society [6]. This pandemic's presence was not unprecedented in history.…”

Section: Introductionmentioning

confidence: 99%

Taste Detection Threshold in Relation to Pfizer COVID-19 Vaccine

Abbas¹,

Zaidan²

2023

Cureus

View full text Add to dashboard Cite

BackgroundThe first hit of the COVID-19 pandemic was reported in December 2019 in Wuhan, Hubei province, China, and wholesale seafood markets were reported to be the source of infection. The development of effective and safe vaccines against SARS-CoV-2 has been extremely fast. The development of the COVID-19 mRNA vaccine started in early January 2020, after the release of the SARS-CoV-2 genetic sequence by the Chinese Center for Disease Control and Prevention and its global dissemination by the Global Initiative on Sharing All Influenza Data (GISAID).

show abstract

“…On January 7, 2020, the causal microorganism was identified as a novel coronavirus (CoV) known as 2019-nCoV. [1][2][3][4] The virus was later termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). [5][6][7] The World Health Organization (WHO) termed the illness coronavirus disease 2019 .…”

Section: Introductionmentioning

confidence: 99%

Serum levels of α1-antitrypsin, interleukin-1β and interleukin-6 in Iraqi COVID-19 patients: A cross-sectional study

2022

View full text Add to dashboard Cite

Background: More than half of the individuals diagnosed with coronavirus disease 2019 (COVID-19) have been found to have high levels of interleukin (IL)-6. A recent report showed that more elevated serum IL-6 level predicts COVID-19 disease severity and patients’ clinical outcomes. Therefore, this study aimed to compare the serum levels of α1-antitrypsin (AAT), IL-1β, and IL-6 between COVID-19 patients and healthy individuals. Methods: During the data collection phase, 90 individuals were enrolled, 45 healthy controls, and 45 patients confirmed with COVID-19 using reverse transcription-quantitative PCR (RT-qPCR) at a specialized isolation hospital in Baghdad between November 2021 and March 2022. In this cross-sectional research, venous blood samples were taken, and serum was isolated and stored for quantitative ELISA measurements of AAT, IL-1β, and IL-6 (ELISA). IBM SPSS version 24 was used to analyze the data. Results: This study revealed a significant increase in the serum levels of AAT, IL-1β, and IL-6 in the COVID-19 patients' group compared to the healthy control group with p-values < 0.001 for each of these markers. Conclusions: AAT concentrations were higher during COVID-19; this elevation is essential during infection. IL-1β and IL-6 levels were also elevated during the infection period; however, dysregulated high levels may lead to cytokine release syndrome. Therefore, these three biomarkers can be regarded as diagnostically crucial parameters.

show abstract

Exacerbation of COVID 19 in Hypertensive Patients ( A review)

Cited by 7 publications

References 46 publications

Effects of Fixed Orthodontic Appliance with Antihypertensive Drugs on the Body Weight of Experimental Rats

Effects of Fixed Orthodontic Appliance with Antihypertensive Drugs on the Body Weight of Experimental Rats

Taste Detection Threshold in Relation to Pfizer COVID-19 Vaccine

Serum levels of α1-antitrypsin, interleukin-1β and interleukin-6 in Iraqi COVID-19 patients: A cross-sectional study

Contact Info

Product

Resources

About